Symbole | YTM % | Volume | Prix % | Coupon % | Date d'échéance | Montant en suspens | Valeur nominale | Montant min de la dénomination | Émetteur |
---|---|---|---|---|---|---|---|---|---|
RPHC5222528Royalty Pharma plc 3.35% 02-SEP-2051 | 7,33% | 921 K | 64,08% | 3,35% | 2051-09-02 | 700 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5237919Royalty Pharma plc 3.55% 02-SEP-2050 | 7,23% | 160 K | 66,98% | 3,55% | 2050-09-02 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5237891Royalty Pharma plc 3.3% 02-SEP-2040 | 6,98% | 601 K | 72,48% | 3,30% | 2040-09-02 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5824522Royalty Pharma plc 5.9% 02-SEP-2054 | 6,35% | 6,3 M | 95,42% | 5,90% | 2054-09-02 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5222527Royalty Pharma plc 2.15% 02-SEP-2031 | 5,80% | 416 K | 82,60% | 2,15% | 2031-09-02 | 600 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5824521Royalty Pharma plc 5.4% 02-SEP-2034 | 5,77% | 8,43 M | 97,72% | 5,40% | 2034-09-02 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5237916Royalty Pharma plc 2.2% 02-SEP-2030 | 5,60% | 624 K | 85,51% | 2,20% | 2030-09-02 | 996,81 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5824520Royalty Pharma plc 5.15% 02-SEP-2029 | 5,15% | 420 K | 100,01% | 5,15% | 2029-09-02 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5237354Royalty Pharma plc 1.75% 02-SEP-2027 | 4,98% | 250 K | 92,59% | 1,75% | 2027-09-02 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5237914Royalty Pharma plc 1.2% 02-SEP-2025 | 4,96% | 1,7 M | 97,84% | 1,20% | 2025-09-02 | 999,96 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5035520Royalty Pharma plc 2.2% 02-SEP-2030 | 2,37% | 0 | 98,72% | 2,20% | 2030-09-02 | 3,19 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5035516Royalty Pharma plc 1.2% 02-SEP-2025 | 1,30% | 0 | 99,62% | 1,20% | 2025-09-02 | 38 K USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |